We found that elevated tumor B7-H3 expression was observed in metastatic tumors after adjuvant chemotherapy compared to that in primary tumors in pair-matched tumor tissues, suggesting that B7-H3 may limit the therapeutic efficacy of adjuvant chemotherapy (Fig. 2B). This evidence concerns the gene CD276 and metastatic neoplasm.